| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/14/2009 | CA2723165A1 Sulfatase enzymes |
| 05/14/2009 | CA2705100A1 Methods of measuring cell viability without using control cells |
| 05/14/2009 | CA2705044A1 Methods for detecting or monitoring cancer using lpc as a marker |
| 05/14/2009 | CA2704974A1 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/14/2009 | CA2704699A1 Method and apparatus for rapidly counting and identifying biological particles in a flow stream |
| 05/14/2009 | CA2704560A1 Use of oligonucleotides with modified bases in hybridization of nucleic acids |
| 05/14/2009 | CA2704494A1 Directed evolution using proteins comprising unnatural amino acids |
| 05/14/2009 | CA2704475A1 Methods of identifying improved nmda receptor antagonists |
| 05/14/2009 | CA2704232A1 Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-cd3/cd28 |
| 05/14/2009 | CA2703877A1 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 05/14/2009 | CA2703852A1 Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 05/14/2009 | CA2703804A1 Mass spectrometry assay for eif4e and eif4e regulon activity |
| 05/14/2009 | CA2703395A1 Mycobacterium antigens |
| 05/14/2009 | CA2703075A1 Moisture indicator for heat and moisture exchange devices |
| 05/14/2009 | CA2700197A1 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 05/13/2009 | EP2058663A1 Method for the immobilization of an analyte on a solid support |
| 05/13/2009 | EP2058662A1 Diagnosis of diseases by measuring cell mediated extracellular matrix degradation |
| 05/13/2009 | EP2058661A1 Fecal occult blood testing device and method |
| 05/13/2009 | EP2058660A1 Nonspecific adsorption inhibitor of substance relating to living body and method for coating article |
| 05/13/2009 | EP2058659A1 Method for determination of molecular weight of hyaluronic acid |
| 05/13/2009 | EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport |
| 05/13/2009 | EP2058657A1 Method for determining bioactivity of molecules |
| 05/13/2009 | EP2058654A1 Apparatus for measuring calcium oxalate scaling |
| 05/13/2009 | EP2058651A1 Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
| 05/13/2009 | EP2058647A1 Sulfur component detection apparatus |
| 05/13/2009 | EP2058408A2 Therapeutic GPCR targets in cancer |
| 05/13/2009 | EP2058407A2 Invasive cleavage of nucleic acids |
| 05/13/2009 | EP2058358A1 Membranes |
| 05/13/2009 | EP2058335A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/13/2009 | EP2058334A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058007A2 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 05/13/2009 | EP2057936A1 Method and system for characterization and mapping of tissue lesions |
| 05/13/2009 | EP2057508A1 Use of squaraine dyes to visualize protein during separations |
| 05/13/2009 | EP2057473A2 Markers of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash) and methods of use thereof |
| 05/13/2009 | EP2057472A2 Method of detecting and/ or measuring hepcidin in a sample |
| 05/13/2009 | EP2057471A2 Methods for diagnosing irritable bowel syndrome |
| 05/13/2009 | EP2057470A1 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody |
| 05/13/2009 | EP2057469A2 Boris isoforms and methods of detecting and treating disease |
| 05/13/2009 | EP2057468A1 Differential diagnosis for scleroderma |
| 05/13/2009 | EP2057467A2 Method for diagnosis of a disease involving an anti-at1-receptor antibody |
| 05/13/2009 | EP2057466A2 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 05/13/2009 | EP2057465A2 Organ-specific proteins and methods of their use |
| 05/13/2009 | EP2057464A2 Detection of hydrogen peroxide released by enzyme-catalyzed oxidation of an analyte |
| 05/13/2009 | EP2057463A1 Diagnose of mycobacterial infections by determination of ifn-gamma |
| 05/13/2009 | EP2057462A1 Method for monitoring the state of an engine oil in an internal combustion engine |
| 05/13/2009 | EP2057461A2 Bio surface acoustic wave (saw) resonator amplification for detection of a target analyte |
| 05/13/2009 | EP2057286A2 Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections |
| 05/13/2009 | EP2057280A2 Method of modulation of protein phosphorylation-dependent conformational transitions with low molecular weight compounds |
| 05/13/2009 | EP2057103A1 Catalytically active component for thermal ionization detectors for the detection of halogen-containing compounds and process for producing an oxide-ceramic material for the component |
| 05/13/2009 | EP2057009A2 Nitric oxide microsensors via fluorosilane-based xerogel membranes |
| 05/13/2009 | EP2056965A1 Fluidic indicator device |
| 05/13/2009 | EP2056870A2 Trypanosome microsome system and uses thereof |
| 05/13/2009 | EP2056849A2 Methods and compositions for treating ige-mediated diseases |
| 05/13/2009 | EP2056827A1 Method for inducing tumor apoptosis by increasing nitric oxide levels |
| 05/13/2009 | EP2021795A4 Cross-species and multi-species display systems |
| 05/13/2009 | EP2016409A4 Bio-chip of pattern-arranged in line, method for manufacturing the same, and method for detecting an analyte bound in the same |
| 05/13/2009 | EP2008094A4 Compound screening method and apparatus |
| 05/13/2009 | EP1977444A4 Sensing devices from molecular electronic devices |
| 05/13/2009 | EP1946111B1 Method and means for determining the replication rate of a viral population |
| 05/13/2009 | EP1934618B1 Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (adsmb) |
| 05/13/2009 | EP1907862B1 Use of the salivary protein cd14 as an indicator of the low risk of developing caries |
| 05/13/2009 | EP1866433B1 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2 |
| 05/13/2009 | EP1856538B1 Determination of short-chain srl-alcohol dehydrogenase (dhrs4) as biomarker of inflammations and infections |
| 05/13/2009 | EP1848804A4 Anti-muci alpha beta antibodies |
| 05/13/2009 | EP1820023B1 Stem cells, method for their purification, identification, and use |
| 05/13/2009 | EP1758565B1 Method of identifying GLP-1 secretagogues |
| 05/13/2009 | EP1725270B1 Methods for uniformly treating biological samples with electromagnetic radiation |
| 05/13/2009 | EP1644858A4 Expression profile algorithm and test for cancer prognosis |
| 05/13/2009 | EP1623007A4 Method and apparatus for preparing cell samples for intracellular antigen detection using flow cytometry |
| 05/13/2009 | EP1560838B1 Labelled nucleotides |
| 05/13/2009 | EP1549210A4 Integrated confirmation sample in a body fluid test device |
| 05/13/2009 | EP1514110A4 An apparatus and method for two-dimensional electron gas actuation and transduction for gaas nems |
| 05/13/2009 | EP1495325B1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1478778B1 Method and nucleic acids for the analysis of a colon cell proliferactive disorder |
| 05/13/2009 | EP1466174B1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 05/13/2009 | EP1446666B1 Method for detecting analyte(s) using magnetic colloidal particles |
| 05/13/2009 | EP1438575A4 System and method for determining radius of gyration, molecular weight, and intrinsic viscosity of a polymeric distribution using gel permeation chromatography and light-scattering detection |
| 05/13/2009 | EP1381673B1 Compositions and methods useful for hcv infection |
| 05/13/2009 | EP1373525B1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 05/13/2009 | EP1350109B1 Marker for inflammatory conditions |
| 05/13/2009 | EP1349879A4 System and method for determining molecular weight and intrinsic viscosity of a polymeric distribution using gel permeation chromatography |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1317464B1 Fluorescent nucleobase conjugates having anionic linkers |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1294891B1 Transport peptides derived from erns protein |
| 05/13/2009 | EP1269172B1 Electrode device with a solid state reference system |
| 05/13/2009 | EP1224297B1 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 05/13/2009 | EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 05/13/2009 | CN201237600Y Strip carrying apparatus of urine analyzer |
| 05/13/2009 | CN201237599Y Strip choosing apparatus of urine analyzer |
| 05/13/2009 | CN201237598Y Test paper carrier bench of urine analyzer |
| 05/13/2009 | CN201237596Y Early pregnancy detector |
| 05/13/2009 | CN201237595Y Exhalation diabetes detection apparatus |
| 05/13/2009 | CN201237594Y Chemical luminescence immunity analysis reagent box for combined detection of multiple infectious disease items |
| 05/13/2009 | CN201237593Y Chemical luminescence immunity analysis reagent box for combined detection of multi-tumor marker |
| 05/13/2009 | CN201237592Y Fabric crease elasticity test instrument |
| 05/13/2009 | CN201237591Y Rock joint shearing-seepage coupling test system |
| 05/13/2009 | CN201237590Y Block needle detection apparatus |